Molecular interactions at the colchicine binding site in tubulin: An X-ray crystallography perspective
Author:
Funder
National Institutes of Health
U.S. Department of Defense
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference143 articles.
1. Surveillance, Epidemiology, and End Results (SEER) Program. Cancer stat facts: cancer of any site. https://seer.cancer.gov/statfacts/html/all.html [Published 2020. Accessed January 4, 2021].
2. Anti-tubulin agents of natural origin: targeting taxol, vinca, and colchicine binding domains;Naaz;Eur J Med Chem,2019
3. Microtubulin binding sites as target for developing anticancer agents;Islam;Mini Rev Med Chem,2004
4. Microtubule polymerization dynamics;Desai;Annu Rev Cell Dev Biol,1997
5. Delta-tubulin and epsilon-tubulin: two new human centrosomal tubulins reveal new aspects of centrosome structure and function;Chang;Nat Cell Biol,2000
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Design and synthesis of novel 3-amino-5-phenylpyrazole derivatives as tubulin polymerization inhibitors targeting the colchicine-binding site;European Journal of Medicinal Chemistry;2024-03
2. Genotoxic effects and mitosis aberrations of chromium (VI) on root cells of Vicia faba and its molecular docking analysis;Plant Physiology and Biochemistry;2024-02
3. Design, synthesis, and bioevaluation of 1 h -pyrrolo[3,2- c ]pyridine derivatives as colchicine-binding site inhibitors with potent anticancer activities;Journal of Enzyme Inhibition and Medicinal Chemistry;2024-01-14
4. Frentizole, a Nontoxic Immunosuppressive Drug, and Its Analogs Display Antitumor Activity via Tubulin Inhibition;International Journal of Molecular Sciences;2023-12-14
5. Design, synthesis and biological evaluation of novel dihydroquinolin-4(1H)-one derivatives as novel tubulin polymerization inhibitors;European Journal of Medicinal Chemistry;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3